Neurotech Pharmaceuticals, Inc. Email Format
Biotechnology ResearchRhode Island, United States51-200 Employees
Neurotech Pharmaceuticals, Inc. is a private biotechnology research company headquartered in Cumberland, Rhode Island, with a workforce of 51 to 200 employees. The company focuses on developing therapies for chronic eye diseases. Its core platform, Encapsulated Cell Therapy (ECT), is a first-in-class drug-delivery technology intended to slow the progression of idiopathic Macular Telangiectasia type 2 in adults and other chronic ocular diseases. Neurotech operates in the biotechnology sector and pursues research and development activities related to ophthalmology. Recent announcements indicate ongoing governance and leadership changes, including board appointments and new chief commercial officer appointments.